Assertio Therapeutics (ASRT) Investor Presentation November 2021

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Assertio Therapeutics outlines its strategy following the completion of workforce restructuring and Zyla Life Sciences merger integration. The company focuses on business development, sustainable growth, operating cash flow generation, and resolution of legacy legal matters to create shareholder value in the specialty pharmaceuticals sector.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Assertio Therapeutics

View all →

presentation

Assertio Therapeutics Investor Presentation — December 2017

investor_presentation

Similar investor_presentations from other companies

Browse all →

Gjensidige Forsikring 2016 Investor Presentation

investor_presentation

16 Pages

Gjensidige Forsikring ASA

Deutsche Post DHL Group Q2 2018 Investor Presentation

investor_presentation